BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555,000 | +27.3% | 11,073 | +60.5% | 0.00% | – |
| Q2 2023 | $436,000 | +50.3% | 6,899 | +6.8% | 0.00% | – |
| Q1 2023 | $290,000 | -45.8% | 6,458 | -47.2% | 0.00% | – |
| Q4 2022 | $535,000 | +117.5% | 12,241 | +227.1% | 0.00% | – |
| Q3 2022 | $246,000 | +2.9% | 3,742 | -20.9% | 0.00% | – |
| Q2 2022 | $239,000 | -50.6% | 4,732 | -37.6% | 0.00% | – |
| Q1 2022 | $484,000 | -74.7% | 7,579 | -57.6% | 0.00% | – |
| Q4 2021 | $1,914,000 | +104.9% | 17,872 | +96.8% | 0.00% | – |
| Q3 2021 | $934,000 | -59.3% | 9,080 | -65.2% | 0.00% | -100.0% |
| Q2 2021 | $2,296,000 | -54.7% | 26,111 | -49.9% | 0.00% | 0.0% |
| Q1 2021 | $5,065,000 | -19.7% | 52,088 | -7.3% | 0.00% | -50.0% |
| Q4 2020 | $6,304,000 | +22.1% | 56,198 | +0.9% | 0.00% | 0.0% |
| Q3 2020 | $5,161,000 | -6.4% | 55,680 | -21.2% | 0.00% | 0.0% |
| Q2 2020 | $5,514,000 | +37.2% | 70,690 | +2.8% | 0.00% | 0.0% |
| Q1 2020 | $4,020,000 | +545.3% | 68,747 | +782.7% | 0.00% | – |
| Q4 2019 | $623,000 | +165.1% | 7,788 | +143.8% | 0.00% | – |
| Q3 2019 | $235,000 | -87.5% | 3,195 | -84.0% | 0.00% | -100.0% |
| Q2 2019 | $1,879,000 | -17.4% | 19,925 | -29.9% | 0.00% | 0.0% |
| Q1 2019 | $2,274,000 | -61.6% | 28,406 | -74.2% | 0.00% | -66.7% |
| Q4 2018 | $5,925,000 | -27.2% | 109,921 | +5.3% | 0.00% | 0.0% |
| Q3 2018 | $8,144,000 | +70.4% | 104,347 | +38.6% | 0.00% | +50.0% |
| Q2 2018 | $4,780,000 | +95500.0% | 75,299 | +141973.6% | 0.00% | – |
| Q1 2018 | $5,000 | -78.3% | 53 | -83.0% | 0.00% | – |
| Q4 2017 | $23,000 | -99.7% | 312 | -99.7% | 0.00% | -100.0% |
| Q3 2017 | $8,292,000 | +138100.0% | 119,025 | +96668.3% | 0.00% | – |
| Q2 2017 | $6,000 | -76.9% | 123 | -80.9% | 0.00% | – |
| Q1 2017 | $26,000 | +13.0% | 643 | -22.2% | 0.00% | – |
| Q4 2016 | $23,000 | – | 827 | +6261.5% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 13 | -96.9% | 0.00% | – |
| Q3 2015 | $9,000 | -40.0% | 419 | -27.0% | 0.00% | – |
| Q2 2015 | $15,000 | – | 574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |